https://www.selleckchem.com/pr....oducts/deutenzalutam
Paroxysmal atrial fibrillation (pAF) is a major risk factor for ischemic stroke, but challenging to detect with routine short-term monitoring methods. In this pilot study, we present a novel method for prolonged ECG and screening for pAF in patients with a recent embolic stroke of unknown source (ESUS). Fifteen patients aged≥50years with a recent ESUS were assigned to wear an external electrode belt-based 1-lead ECG device (Beat2Phone) continuously for 2weeks (wear time). The device was operated via a mobile phone application i
Like
Comment
Share
